CCK and obesity disorder: Our studies clearly established the in vivo role of CCK-induced airway constriction as blocking the heightened CCK/CCKAR signaling using potent antagonists decreased the pulmonary resistance to methacholine challenge in two distinct mouse models of obesity-associated asthma—a genetically obese mouse model and a diet-induced mouse model.